Queen's University Belfast is one of the leading universities in the UK and Ireland, with a distinguished heritage and history. With over 24,000 students, 4,200 staff and an annual turnover of some GBP 300m, Queen's University Belfast plays a unique leadership role in Northern Ireland. As a member of the Russell Group of UK research-intensive universities, Queen's University Belfast combines excellence in research and education with a student centred ethos.
Queen's University has generous terms and conditions of employment underpinned by excellent benefits. We also provide attractive well-being, family friendly and other lifestyle benefits.
The Centre for Experimental Medicine is an interdisciplinary research centre which is committed to the highest quality scientific endeavour, with over 250 basic and clinical scientists working on site. Our mission is to understand the mechanisms of disease and use that understanding to develop innovative new treatments and therapies to improve patient outcomes. We are based in Belfast in the award winning Wellcome-Wolfson Institute for Experimental Medicine.
We are recruiting for Research Fellows in Epigenetics who will be highly productive, ambitious and collaborative members of the Gene Regulation Group led by Dr. Vijay Tiwariin the Centre for Experimental Medicine. The positions will contribute to internationally competitive research on epigenetic regulation of cell-fate specification during development. The group employs high-throughput genomics assays and cutting-edge epigenetics and molecular biology tools in combination with stem cell biology and neurobiology. The resulting datasets are analysed using computational and systems biology approaches to generate a comprehensive model of epigenetic regulation of gene expression during embryonic development. The successful applicants will have responsibilities in independent research,supervision, planning, day-to-day lab management, collaborations and outreach.
These posts are suited to highly ambitious individuals. Post 1 is available initially for one year with possibility of extension and Post 2 is available until 31 October 2021.